285 related articles for article (PubMed ID: 31229593)
1. Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial.
Shengchen D; Gu X; Fan G; Sun R; Wang Y; Yu D; Li H; Zhou F; Xiong Z; Lu B; Zhu G; Cao B
Clin Microbiol Infect; 2019 Nov; 25(11):1415-1421. PubMed ID: 31229593
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Molecular Point-of-Care Testing for Respiratory Pathogens in Children With Respiratory Infections: A Retrospective Case-Control Study.
Shen N; Zhou Y; Zhou Y; Luo L; Chen W; Wang J; Zhao R; Xie L; Cao Q; Tao Y; Mo X
Front Cell Infect Microbiol; 2021; 11():778808. PubMed ID: 34869077
[TBL] [Abstract][Full Text] [Related]
3. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.
Brendish NJ; Malachira AK; Armstrong L; Houghton R; Aitken S; Nyimbili E; Ewings S; Lillie PJ; Clark TW
Lancet Respir Med; 2017 May; 5(5):401-411. PubMed ID: 28392237
[TBL] [Abstract][Full Text] [Related]
4. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection.
Oosterheert JJ; van Loon AM; Schuurman R; Hoepelman AI; Hak E; Thijsen S; Nossent G; Schneider MM; Hustinx WM; Bonten MJ
Clin Infect Dis; 2005 Nov; 41(10):1438-44. PubMed ID: 16231254
[TBL] [Abstract][Full Text] [Related]
5. Impact of multiplex respiratory virus testing on antimicrobial consumption in adults in acute care: a randomized clinical trial.
Saarela E; Tapiainen T; Kauppila J; Pokka T; Uhari M; Kauma H; Renko M
Clin Microbiol Infect; 2020 Apr; 26(4):506-511. PubMed ID: 31574339
[TBL] [Abstract][Full Text] [Related]
6. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use.
Andrews D; Chetty Y; Cooper BS; Virk M; Glass SK; Letters A; Kelly PA; Sudhanva M; Jeyaratnam D
BMC Infect Dis; 2017 Oct; 17(1):671. PubMed ID: 29017451
[TBL] [Abstract][Full Text] [Related]
7. Impact of a rapid respiratory panel test on patient outcomes.
Rogers BB; Shankar P; Jerris RC; Kotzbauer D; Anderson EJ; Watson JR; O'Brien LA; Uwindatwa F; McNamara K; Bost JE
Arch Pathol Lab Med; 2015 May; 139(5):636-41. PubMed ID: 25152311
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
[TBL] [Abstract][Full Text] [Related]
9. Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC).
Brendish NJ; Malachira AK; Clark TW
BMC Infect Dis; 2017 Feb; 17(1):128. PubMed ID: 28166743
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial.
Do NT; Ta NT; Tran NT; Than HM; Vu BT; Hoang LB; van Doorn HR; Vu DT; Cals JW; Chandna A; Lubell Y; Nadjm B; Thwaites G; Wolbers M; Nguyen KV; Wertheim HF
Lancet Glob Health; 2016 Sep; 4(9):e633-41. PubMed ID: 27495137
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
[TBL] [Abstract][Full Text] [Related]
12. Combining Procalcitonin and Rapid Multiplex Respiratory Virus Testing for Antibiotic Stewardship in Older Adult Patients With Severe Acute Respiratory Infection.
Lee CC; Chang JC; Mao XW; Hsu WT; Chen SY; Chen YC; How CK
J Am Med Dir Assoc; 2020 Jan; 21(1):62-67. PubMed ID: 31791902
[TBL] [Abstract][Full Text] [Related]
13. Using point-of-care C-reactive protein to guide antibiotic prescribing for lower respiratory tract infections in elderly nursing home residents (UPCARE): study design of a cluster randomized controlled trial.
Boere TM; van Buul LW; Hopstaken RM; Veenhuizen RB; van Tulder MW; Cals JWL; Verheij TJM; Hertogh CMPM
BMC Health Serv Res; 2020 Feb; 20(1):149. PubMed ID: 32103747
[TBL] [Abstract][Full Text] [Related]
14. Novel multi-virus rapid respiratory microbiological point-of-care testing in primary care: a mixed-methods feasibility evaluation.
Khalid TY; Duncan LJ; Thornton HV; Lasseter G; Muir P; Toney ZA; Hay AD
Fam Pract; 2021 Sep; 38(5):598-605. PubMed ID: 33684208
[TBL] [Abstract][Full Text] [Related]
15. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
[TBL] [Abstract][Full Text] [Related]
17. Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods.
Hammond SP; Gagne LS; Stock SR; Marty FM; Gelman RS; Marasco WA; Poritz MA; Baden LR
J Clin Microbiol; 2012 Oct; 50(10):3216-21. PubMed ID: 22814461
[TBL] [Abstract][Full Text] [Related]
18. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial.
Poole S; Tanner AR; Naidu VV; Borca F; Phan H; Saeed K; Grocott MPW; Dushianthan A; Moyses H; Clark TW
J Infect; 2022 Dec; 85(6):625-633. PubMed ID: 36096312
[TBL] [Abstract][Full Text] [Related]
19. Health service impact of testing for respiratory pathogens using cartridge-based multiplex array versus molecular batch testing.
Madigan VM; Sinickas VG; Giltrap D; Kyriakou P; Ryan K; Chan HT; Clifford V
Pathology; 2018 Dec; 50(7):758-763. PubMed ID: 30389216
[TBL] [Abstract][Full Text] [Related]
20. Effect of Point-of-Care Testing for Respiratory Pathogens on Antibiotic Use in Children: A Randomized Clinical Trial.
Mattila S; Paalanne N; Honkila M; Pokka T; Tapiainen T
JAMA Netw Open; 2022 Jun; 5(6):e2216162. PubMed ID: 35679047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
